We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$16.6B
AUM Growth
+$973M
Cap. Flow
-$466M
Cap. Flow %
-2.8%
Top 10 Hldgs %
30.85%
Holding
337
New
11
Increased
98
Reduced
190
Closed
11

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$43.9M
2
DELL icon
Dell
DELL
+$36.8M
3
CME icon
CME Group
CME
+$29.7M
4
AFG icon
American Financial Group
AFG
+$18.4M
5
WMB icon
Williams Companies
WMB
+$16.6M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$49.2M
2
AVGO icon
Broadcom
AVGO
+$43.2M
3
UPS icon
United Parcel Service
UPS
+$26.7M
4
PLD icon
Prologis
PLD
+$26.4M
5
ABT icon
Abbott
ABT
+$26M

Sector Composition

Rank Sector Weight
1 Technology 22.48%
2 Healthcare 14.22%
3 Financials 13.06%
4 Industrials 12.03%
5 Consumer Staples 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
201
Verizon
VZ
$196B
$2.25M 0.01%
59,806
-2,171
-4% -$76.8K
BMY icon
202
Bristol-Myers Squibb
BMY
$132B
$2.23M 0.01%
43,385
-4,220
-9% -$222K
NVDA icon
203
NVIDIA
NVDA
$5.42T
$2.18M 0.01%
44,100
+8,070
+22% +$374K
EOG icon
204
EOG Resources
EOG
$70.7B
$2.13M 0.01%
17,600
-275
-2% -$34.2K
LYB icon
205
LyondellBasell Industries
LYB
$19.2B
$2.01M 0.01%
21,155
-5,752
-21% -$538K
PM icon
206
Philip Morris
PM
$295B
$1.97M 0.01%
20,971
-120
-0.6% -$11.1K
WPC icon
207
W.P. Carey
WPC
$16.4B
$1.92M 0.01%
29,656
-2,767
-9% -$159K
COHR icon
208
Coherent
COHR
$74.2B
$1.91M 0.01%
43,829
+4,900
+13% +$177K
KMB icon
209
Kimberly-Clark
KMB
$36.5B
$1.87M 0.01%
15,362
-790
-5% -$95.5K
DEO icon
210
Diageo
DEO
$53.6B
$1.83M 0.01%
12,567
-195
-2% -$28.8K
EXPO icon
211
Exponent
EXPO
$3.24B
$1.79M 0.01%
20,339
-7,730
-28% -$633K
VIGI icon
212
Vanguard International Dividend Appreciation ETF
VIGI
$9.3B
$1.76M 0.01%
22,183
+4,663
+27% +$344K
TMO icon
213
Thermo Fisher Scientific
TMO
$220B
$1.75M 0.01%
3,291
-75
-2% -$36.3K
SCL icon
214
Stepan Co
SCL
$1.48B
$1.74M 0.01%
18,426
-6,052
-25% -$483K
TFC icon
215
Truist Financial
TFC
$64B
$1.73M 0.01%
46,856
-19,961
-30% -$627K
AIT icon
216
Applied Industrial Technologies
AIT
$13.3B
$1.73M 0.01%
10,000
CNMD icon
217
CONMED
CNMD
$1.47B
$1.69M 0.01%
15,434
+207
+1% +$21.4K
STE icon
218
Steris
STE
$23.1B
$1.69M 0.01%
7,684
-1,019
-12% -$216K
GPC icon
219
Genuine Parts
GPC
$18.7B
$1.68M 0.01%
12,158
-1,856
-13% -$255K
CL icon
220
Colgate-Palmolive
CL
$74.4B
$1.67M 0.01%
20,967
-11
-0.1% -$827
PRGS icon
221
Progress Software
PRGS
$1.76B
$1.66M 0.01%
30,637
+813
+3% +$43.1K
NDSN icon
222
Nordson
NDSN
$17.3B
$1.54M 0.01%
5,838
+800
+16% +$185K
GIS icon
223
General Mills
GIS
$19.7B
$1.47M 0.01%
22,560
-27
-0.1% -$1.74K
SJM icon
224
J.M. Smucker
SJM
$12.8B
$1.46M 0.01%
11,583
-301
-3% -$34.9K
PYPL icon
225
PayPal
PYPL
$50.5B
$1.46M 0.01%
23,772
+19,732
+488% +$1.13M

Similar funds

Bahl & Gaynor's Q4 2023 Portfolio in Review

As of Q4 2023, Bahl & Gaynor held 337 positions worth $16.6B, up 6.2% from $15.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2023 filing shows 11 new, 98 increased, 190 reduced and 11 closed positions. Its largest new stake was Dell: 520,900 shares worth $39.8M. The largest sale was Medtronic, an estimated $49.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2023 buy was Dell: 520,900 shares worth $39.8M.
  • Bahl & Gaynor added most to Amgen in Q4 2023, an estimated $43.9M increase.
  • Bahl & Gaynor's biggest Q4 2023 reduction was Medtronic, cutting an estimated $49.2M.
  • Bahl & Gaynor fully exited SBA Communications in Q4 2023, selling an estimated $375K.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $16.6B portfolio in Q4 2023.
  • Bahl & Gaynor opened 11 new positions and closed 11 in Q4 2023.
  • Bahl & Gaynor's portfolio value rose 6.2% quarter-over-quarter to $16.6B.

Based on Bahl & Gaynor's 13F filing for Q4 2023, filed 2 Feb 2024.